Our data suggest that PTP1B deficiency enhances insulin signaling in the conditions of hypoinsulinemic diabetes and eNOS deficiency, increases adaptive sXBP-1 signaling, reduces maladaptive CHOP expression, and attenuates diabetic podocyte injury in vivo. Here, INS is linked to diabetes mellitus.